Specialty Cardiovascular
-
Featured
DCD Donor Hearts Safely Expand Donor Organ Pool
Massachusetts General Hospital is one of five donation after circulatory death (DCD) heart transplant centers in the U.S., investigating DCD donor hearts for transplantation.
-
Accelerometer Data Confirms: Increased Physical Activity Is Associated with Reduced Risk of Afib, Stroke
Using wrist-worn accelerometer data from the UK Biobank, Shaan Khurshid, MD, MPH, and Steven A. Lubitz, MD, MPH, of the Cardiovascular Research Center, and colleagues confirmed guideline-recommended levels of physical activity are associated with substantially lower risks of incident atrial fibrillation and stroke.
-
Polygenic Scores for Cardiometabolic Diseases Correlate Strongly Across Siblings
In a study with substantial implications for genetic counseling, Amit V. Khera, MD, MSc, of the Center for Genomic Medicine, and colleagues found that when individuals with high polygenic scores were defined as those in the top 20% of the distribution, about 45% of their siblings met the same threshold.
-
Use of ACE Inhibitors, ARBs by Households of COVID-19 Patients Linked to Lower Risk
In the first large study of people taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers who had known exposure to SARS-CoV-2, researchers at Massachusetts General Hospital found those drug classes were associated with reduced risk of a COVID-19 diagnosis.
-
X Chromosome Locus Is Associated with Lower Atherogenic Lipids, Favorable Cardiometabolic Traits
Variants in chromosome Xq23 are linked to reduced total cholesterol, LDL cholesterol and triglycerides, and reduced risk of coronary heart disease and type 2 diabetes, according to whole-genome data analyzed by Pradeep Natarajan, MD, MMSc, and an international team of colleagues.
-
Infection of the Heart Commonly Seen at Autopsy of Patients Who Died of COVID-19
In the most detailed study to date, Mayara Bearse, MD, and James R. Stone, MD, PhD, of the Department of Pathology, and colleagues, cardiac infection by SARS-CoV-2 was evident in 73% of autopsies of patients who died of COVID-19 and was linked to differences in clinical features and treatment.
Cardiovascular Contributors
-
Aaron L. Baggish, MD
Director, Cardiovascular Performance Program, Director, Cardiovascular Performance Program Fellowship
Recent Article
Return-to-Play Screening After COVID-19 for All Athletes
-
Ahmed A. Tawakol, MD
Co-Director, Cardiac MR PET CT Program
Recent Article
Neural Activity on PET/CT Independently Associates with Subsequent Takotsubo Syndrome
-
Ami B. Bhatt, MD
Director, Mass General Adult Congenital Heart Disease Program, Director, Outpatient Cardiology
Recent Article
A Hybrid Model of In-person and Telemedicine Visits Facilitates Longitudinal Care Delivery
-
Anthony Rosenzweig, MD
Chief, Cardiology Division, Co-Director, Corrigan Minehan Heart Center
Recent Article
Medical Grand Rounds: Cardiac Manifestations of COVID-19
-
Farouc A. Jaffer, MD, PhD
Director, Coronary Intervention, Massachusetts General Hospital, Director, MGH Chronic Total Occlusion (CTO) Percutaneous Coronary Intervention (PCI) program, Associate Physician, MGH Cardiology, Department of Medicine
Recent Article
Reducing Post-Thrombotic Syndrome Through Reperfusion After DVT May Be Time-Sensitive
-
Hanna K. Gaggin, MD, MPH
Assistant Physician, Massachusetts General Hospital, Assistant Professor, Harvard Medical School
Recent Article
Review: Predicting Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction
-
Jagmeet P. Singh, MD, PhD
Attending Physician, Cardiac Arrhythmia Service, Massachusetts General Hospital
Recent Article
CRT Improves Left Ventricular Function for Chemotherapy-Induced Cardiomyopathy Patients
-
James Louis Januzzi, MD
Hutter Family Professor of Medicine, Director, Dennis and Marilyn Barry Fellowship in Cardiology Research
Recent Article
Type 2 Myocardial Infarction Is Prevalent in U.S., Has a Distinct Clinical Profile
-
Jason H. Wasfy, MD
Medical Director, Massachusetts General Physicians Organization, Director of Quality and Analytics, Massachusetts General Hospital Heart Center
Recent Article
Role of Cardiologists in Evaluation of Type 2 Myocardial Infarction Unclear
-
Jennifer E. Ho, MD
Cardiologist, Heart Failure and Transplantation Program, Assistant Professor of Medicine, Harvard Medical School
Recent Article
Age Influences the Effect of Risk Factors on Development of Heart Failure
-
Kenneth Rosenfield, MD, MHCDS
Section Head, Vascular Medicine and Intervention, Chairman, STEMI & Acute MI Quality Improvement Committee
Recent Article
Mass General Provides Guidance for Anticoagulation in Patients with COVID-19
-
Nasrien E. Ibrahim, MD
Associate Director, Resynchronization & Advanced Cardiac Therapeutics Program
Recent Article
Caution Needed When Interpreting BNP During Sacubitril/Valsartan Treatment
-
Steven A. Lubitz, MD, MPH
Cardiac Electrophysiologist
Recent Article
Accelerometer Data Confirms: Increased Physical Activity Is Associated with Reduced Risk of Afib, Stroke
-
Thoralf M. Sundt, MD
Chief, Division of Cardiac Surgery, Director, Corrigan Minehan Heart Center
Recent Article
Non–Vitamin K Antagonist Oral Anticoagulants Are Safe for Selected Patients with Postoperative AF
-
Tomas G. Neilan, MD, MPH
Director, Cardio-Oncology Program, Massachusetts General Hospital, Co-Director, Cardiac MR PET CT Program
Recent Article
T1 Value on Cardiac MRI Diagnoses Myocarditis Associated with Checkpoint Inhibitors
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.Resource links
